PENZYME
LIVE

Serial Number

79411612

Owner

Enzymatica AB (publ)

Attorney

Maurine Knutsson

Filing Date

Oct 17, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PENZYME Trademark

Serial Number: 79411612 • Registration: 8112758

PENZYME is a trademark filed by Enzymatica AB (publ) on October 17, 2024. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Enzymatica AB (publ) (4 trademarks)

Ideon Science Park

Entity Type: 99

Trademark Details

Filing Date

October 17, 2024

Registration Date

January 27, 2026

Published for Opposition

December 9, 2025

Goods & Services

non-medicated skin care preparations; skin moisturizing gel and skin lotions; hair-care preparations; dentifrices, dental care preparations, namely, dental bleaching gels and creams, and non-medicated dental rinses; beauty, skin, bath, and bar soaps; perfumes; essential oils; cosmetics; natural cosmetics

pharmaceutical preparations for skin care and wounds; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating allergies, hypertension, sunburn, asthma, hypoglycaemia, dandruff, chemical imbalances, diabetes, halitosis, and skin disorders; pharmaceutical preparations for treatment and prevention of cardiovascular, oncological, pulmonary, kidney, autoimmune, metabolic, endocrine, musculoskeletal, genitourinary, neurological, gastrointestinal, and hepatological diseases and disorders; pharmaceutical preparations for the treatment and prevention of damaged skin and tissue, acne, infectious diseases, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, sleep disorders, psychiatric diseases and disorders, viral infections and diseases, and bacterial infections and diseases; veterinary preparations, namely, antioxidants and pain relief medication; veterinary preparations for treatment of intestinal bacteria; veterinary pharmaceutical preparations for treatment and prevention of cardiovascular, oncological, pulmonary, kidney, autoimmune, metabolic, endocrine, musculoskeletal, genitourinary, neurological, gastrointestinal, and hepatological diseases and disorders; veterinary pharmaceutical preparations for the treatment and prevention of damaged skin and tissue, acne, infectious diseases, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, sleep disorders, psychiatric diseases and disorders, viral infections and diseases, and bacterial infections and diseases; medical preparations for preventing or treating colds being viral infections and diseases; medical preparations, gel and lotions for skin treatment; medicated mouth care preparations; chewing gums for medical purposes; sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, nutraceuticals for treatment and prevention of cardiovascular, oncological, pulmonary, kidney, autoimmune, metabolic, endocrine, musculoskeletal, genitourinary, neurological, gastrointestinal, and hepatological diseases and disorders; dietetic substances adapted for medical use, namely, nutraceuticals for the treatment and prevention of damaged skin and tissue, acne, infectious diseases, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, sleep disorders, psychiatric diseases and disorders, viral infections and diseases, and bacterial infections and diseases; dietetic substances adapted for medical use, namely, nutraceuticals for use as a dietary supplement; dietetic supplements, beverages, foods, sugar, sugar substitutes, and confectionaries adapted for medical purposes and medical use; dietetic preparations adapted for medical purposes; medicinal drinks; vitamin preparations and mineral supplements; medicated bath preparations and medicated bath salts; medical plasters; materials for dressings, namely, bandages for dressings, burn dressings, first aid dressings, medical dressings, sterilized dressings, and wound dressings; anti-inflammatory sprays; disinfectants; fungicides, herbicides; enzymes and enzyme preparations for medical purposes

enzyme substrates, other than for medical or veterinary purposes; activator enzymes for use in the manufacture of mouth sprays, nose sprays, pharmaceuticals, nutraceuticals, food, cosmetic preparations, cosmetic formulations, skin care preparations, pharmaceutical preparations, creams and lotions for skin care and skin treatment, dental preparations, dentifrices, hair care preparations, soaps, bath salts, cosmetics, essential oils, perfumes, and natural cosmetics; enzyme stabilizers; enzymes for scientific purposes; enzymes for industrial purposes; enzyme preparations for industrial purposes; enzyme substrates for scientific purposes; purified enzymes for industrial use; enzymes, other than for medical or veterinary use

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 21, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 4, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 4, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 27, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 27, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 27, 2026 R.PR
NOTIFICATION PROCESSED BY IB
Dec 11, 2025 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 25, 2025 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 12, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 12, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 12, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 12, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 22, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 22, 2025 TROA
REFUSAL PROCESSED BY IB
Jun 7, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 21, 2025 RFCS
REFUSAL PROCESSED BY MPU
May 21, 2025 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Mar 28, 2025 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 26, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 25, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 9, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 9, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 5, 2024 REPR